PNC Financial Services Group’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-55
Closed 4563
2016
Q2
$0 Sell
55
-2
-4% -$13 ﹤0.01% 4634
2016
Q1
$1K Buy
57
+30
+111% +$596 ﹤0.01% 4460
2015
Q4
$1K Hold
27
﹤0.01% 4410
2015
Q3
$1K Buy
27
+1
+4% +$48 ﹤0.01% 4565
2015
Q2
$2K Buy
26
+12
+86% +$846 ﹤0.01% 4495
2015
Q1
$2K Hold
14
﹤0.01% 4387
2014
Q4
$1K Buy
+14
New +$1.33K ﹤0.01% 4093

Other funds holding PTX

PNC Financial Services Group's PTX Position: Q3 2016 in Review

PNC Financial Services Group sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q3 2016, closing a stake of 55 shares.

PNC Financial Services Group first reported a position in PTX in Q4 2014 and held it in 7 quarters. The position peaked at $2K in Q2 2015. 48 funds tracked by Wall St. Rank hold PTX as of Q3 2016.

  • PNC Financial Services Group reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q3 2016 after selling out during the quarter.
  • PNC Financial Services Group sold 55 Pernix Therapeutics Holdings, Inc. shares in Q3 2016.
  • PNC Financial Services Group first reported a position in Pernix Therapeutics Holdings, Inc. in Q4 2014 and held it in 7 quarters.
  • PNC Financial Services Group's Pernix Therapeutics Holdings, Inc. position peaked at $2K in Q2 2015.
  • 48 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q3 2016.

Based on PNC Financial Services Group's 13F filing for Q3 2016, filed 4 Nov 2016.